Literature DB >> 8085250

On the inhibitory effect of chloroquine on blood platelet aggregation.

V Jancinová1, R Nosál, M Petríková.   

Abstract

Chloroquine inhibited aggregation of rat blood platelets in a dose-dependent way. The inhibitory effect decreased, depending on the aggregation stimulus used, in the rank order of potency: ADP > thrombin > A23187. Effect of 1 millimolar chloroquine on A23187-stimulated aggregation was significantly decreased or completely abolished by addition of Ca2+ ions in the concentration of 0.1 or 1 mmol/l, respectively. For thrombin-stimulated aggregation the effect of chloroquine was partially decreased by corresponding isomolar calcium; platelet aggregation induced by ADP was not changed in the presence of extracellular Ca2+ ions. Addition of chloroquine during aggregation resulted in disaggregation of ADP-stimulated platelets and inhibition of thrombin- and A23187-induced aggregation.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8085250     DOI: 10.1016/0049-3848(94)90270-4

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


  14 in total

1.  Long-term use of hydroxychloroquine reduces antiphospholipid antibodies levels in patients with primary antiphospholipid syndrome.

Authors:  Entela Nuri; Mara Taraborelli; Laura Andreoli; Marta Tonello; Maria Gerosa; Antonia Calligaro; Lorenza Maria Argolini; Rajesh Kumar; Vittorio Pengo; Pier Luigi Meroni; Amelia Ruffatti; Angela Tincani
Journal:  Immunol Res       Date:  2017-02       Impact factor: 2.829

2.  Effect of hydroxychloroquine treatment on pro-inflammatory cytokines and disease activity in SLE patients: data from LUMINA (LXXV), a multiethnic US cohort.

Authors:  R Willis; A M Seif; G McGwin; L A Martinez-Martinez; E B González; N Dang; E Papalardo; J Liu; L M Vilá; J D Reveille; G S Alarcón; S S Pierangeli
Journal:  Lupus       Date:  2012-02-17       Impact factor: 2.911

Review 3.  Hydroxychloroquine may be beneficial in preeclampsia and recurrent miscarriage.

Authors:  Claire de Moreuil; Zarrin Alavi; Elisabeth Pasquier
Journal:  Br J Clin Pharmacol       Date:  2019-12-17       Impact factor: 4.335

4.  Chloroquine stimulates nitric oxide synthesis in murine, porcine, and human endothelial cells.

Authors:  D Ghigo; E Aldieri; R Todde; C Costamagna; G Garbarino; G Pescarmona; A Bosia
Journal:  J Clin Invest       Date:  1998-08-01       Impact factor: 14.808

Review 5.  New approaches for managing antiphospholipid syndrome.

Authors:  Doruk Erkan; Michael D Lockshin
Journal:  Nat Clin Pract Rheumatol       Date:  2009-03

Review 6.  Current and Future Use of Chloroquine and Hydroxychloroquine in Infectious, Immune, Neoplastic, and Neurological Diseases: A Mini-Review.

Authors:  Domenico Plantone; Tatiana Koudriavtseva
Journal:  Clin Drug Investig       Date:  2018-08       Impact factor: 3.580

7.  Hydroxychloroquine and Mortality Among Patients With Systemic Lupus Erythematosus in the General Population.

Authors:  April Jorge; Natalie McCormick; Na Lu; Yufei Zheng; John Esdaile; Mary De Vera; Hyon Choi; J Antonio Aviña-Zubieta
Journal:  Arthritis Care Res (Hoboken)       Date:  2021-07-07       Impact factor: 5.178

8.  Antimalarial drugs impact chemical messenger secretion by blood platelets.

Authors:  Kang Xiong-Hang; Jiayi He; Kaila Kemnetz-Ness; Christy Haynes
Journal:  Biochem Biophys Rep       Date:  2020-04-22

Review 9.  Hydroxychloroquine and Covid-19: A Cellular and Molecular Biology Based Update.

Authors:  Amit Pal; Anil Pawar; Kalyan Goswami; Praveen Sharma; Rajendra Prasad
Journal:  Indian J Clin Biochem       Date:  2020-06-10

Review 10.  Revisiting the molecular mechanism of neurological manifestations in antiphospholipid syndrome: beyond vascular damage.

Authors:  M Carecchio; R Cantello; C Comi
Journal:  J Immunol Res       Date:  2014-03-13       Impact factor: 4.818

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.